|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C12Q 1/68 | |
| G01N 33/574 |
| (11) | Number of the document | 2443252 |
| (13) | Kind of document | T |
| (96) | European patent application number | 10725045.8 |
| Date of filing the European patent application | 2010-06-15 | |
| (97) | Date of publication of the European application | 2012-04-25 |
| (45) | Date of publication and mention of the grant of the patent | 2017-11-29 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2010/003563 |
| Date | 2010-06-15 |
| (87) | Number | WO 2010/145796 |
| Date | 2010-12-23 |
| (30) | Number | Date | Country code |
| 09008042 | 2009-06-19 | EP | |
| 09012197 | 2009-09-25 | EP |
| (72) |
STROH, Christopher, DE
VON HEYDEBRECK, Anja, DE
|
| (73) |
Merck Patent GmbH,
Frankfurter Strasse 250, 64293 Darmstadt,
DE
|
| (54) | BIOMARKERS AND METHODS FOR DETERMINING EFFICACY OF ANTI-EGFR ANTIBODIES IN CANCER THERAPY |
| BIOMARKERS AND METHODS FOR DETERMINING EFFICACY OF ANTI-EGFR ANTIBODIES IN CANCER THERAPY |